6 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

Allergan plc (AGN) is seeing ratings go up from a C last week to a B this week. Allergan plc is a healthcare company focused on developing and commercializing pharmaceuticals, biologics, and medical devices. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of AGN stock.

NeuroDerm Ltd. (NDRM) improves from a C to a B rating this week. For more information, get Portfolio Grader’s complete analysis of NDRM stock.

MediWound Ltd. (MDWD) boosts its rating from a C to a B this week. The company also gets A’s in sales growth and earnings surprise. For more information, get Portfolio Grader’s complete analysis of MDWD stock.

Titan Pharmaceuticals, Inc. (TTNP) gets a higher grade this week, advancing from a C last week to a B. For more information, get Portfolio Grader’s complete analysis of TTNP stock.

This week, AcelRx Pharmaceuticals, Inc. (ACRX) pushes up from a C to a B rating. AcelRx Pharmaceuticals, Inc. focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain. The company also gets A’s in sales growth, earnings growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of ACRX stock.

The rating of Bio-Path Holdings, Inc. (BPTH) moves up this week, rising from a C to a B. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of BPTH stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.